167 related articles for article (PubMed ID: 29171939)
1. Initial flow cytometric evaluation of the Clearllab lymphoid screen.
Hedley BD; Cheng G; Luider J; Kern W; Lozanski G; Chin-Yee I; Lowes LE; Keeney M; Careaga D; Magari R; Tejidor L
Cytometry B Clin Cytom; 2018 Sep; 94(5):707-713. PubMed ID: 29171939
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study evaluation of the ClearLLab 10C panels.
Hedley BD; Cheng G; Keeney M; Kern W; Padurean A; Luider J; Chin-Yee I; Lowes LE; Rohrbach J; Ortega R; Smit A; Lo KW; Magari R; Tejidor L
Cytometry B Clin Cytom; 2021 Mar; 100(2):225-234. PubMed ID: 32667744
[TBL] [Abstract][Full Text] [Related]
3. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
Rajab A; Porwit A
Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
[TBL] [Abstract][Full Text] [Related]
4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of the ClearLLab 10C B cell tube.
Espasa A; Torrents S; Morales-Indiano C; Rico LG; Bardina J; Ancochea A; Bistué-Rovira À; Linio R; Raya M; Vergara S; Juncà J; Grifols JR; Petriz J; Soria MG; Sorigue M
Cytometry B Clin Cytom; 2021 Jul; 100(4):519-530. PubMed ID: 32961011
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
[TBL] [Abstract][Full Text] [Related]
7. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract][Full Text] [Related]
8. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract][Full Text] [Related]
10. A ten-color tube with dried antibody reagents for the screening of hematological malignancies.
Correia RP; Rajab A; Bento LC; Alexandre AM; Vaz AC; Schimidell D; Pedro EC; Perin FS; Nozawa ST; Barroso RS; Bacal NS
Int J Lab Hematol; 2018 Apr; 40(2):136-143. PubMed ID: 28980400
[TBL] [Abstract][Full Text] [Related]
11. Novel lymphocyte screening tube using dried monoclonal antibody reagents.
Hedley BD; Keeney M; Popma J; Chin-Yee I
Cytometry B Clin Cytom; 2015; 88(6):361-70. PubMed ID: 25944189
[TBL] [Abstract][Full Text] [Related]
12. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets.
Gounari E; Tsavdaridou V; Ioakeimidou A; Haidich AB; Skoura L
Scand J Clin Lab Invest; 2019 Nov; 79(7):475-483. PubMed ID: 31497995
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa.
Glencross DK; Swart L; Pretorius M; Lawrie D
Afr J Lab Med; 2022; 11(1):1458. PubMed ID: 35937760
[TBL] [Abstract][Full Text] [Related]
15. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
17. One tube with eight antibodies for 14-part bone marrow leukocyte differential using flow cytometry.
Jacob MC; Souvignet A; Pont J; Solly F; Mondet J; Kesr S; Pernollet M; Dumestre-Perard C; Campos L; Cesbron JY
Cytometry B Clin Cytom; 2017 Jul; 92(4):299-309. PubMed ID: 26990701
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
19. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
20. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
